Breast Imaging in the Era of Molecular Medicine

Breast Imaging in the Era of Molecular Medicine

Monday, Nov. 29, 8:30 AM - 12:00 PM

Presenters are sharing a host of studies that indicate the value and evolving role of molecular imaging in breast imaging. Topics include: molecular pathways that define breast cancer subtypes, applications of screening and diagnostic molecular breast imaging, therapeutic monitoring with PET/CT, pre-surgical planning with MRI and much more. The session is concluding with a panel discussion of the future of breast imaging.

The speakers are:
  • Robyn L. Birdwell, MD, director, breast imaging, Dana-Farber Cancer Institute in Boston; and
  • Homer A. Macapinlac, MD, professor, nuclear medicine, MD Anderson Cancer Center in Houston.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.